Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A.

MLA

Mancuso, M. E., et al. “Source and Purity of Factor VIII Products as Risk Factors for Inhibitor Development in Patients with Hemophilia A.” Journal of Thrombosis and Haemostasis : JTH, vol. 10, no. 5, May 2012, pp. 781–90. EBSCOhost, https://doi.org/10.1111/j.1538-7836.2012.04691.x.

APA

Mancuso, M. E., Mannucci, P. M., Rocino, A., Garagiola, I., Tagliaferri, A., & Santagostino, E. (2012). Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A. Journal of Thrombosis and Haemostasis : JTH, 10(5), 781–790. https://doi.org/10.1111/j.1538-7836.2012.04691.x

Chicago

Mancuso, M E, P M Mannucci, A Rocino, I Garagiola, A Tagliaferri, and E Santagostino. 2012. “Source and Purity of Factor VIII Products as Risk Factors for Inhibitor Development in Patients with Hemophilia A.” Journal of Thrombosis and Haemostasis : JTH 10 (5): 781–90. doi:10.1111/j.1538-7836.2012.04691.x.